Literature DB >> 3767489

A self-sealing dialysis prosthesis. Coaxial double PTFE-silicone graft.

H Schanzer, G P Martinelli, G Bock, E C Peirce.   

Abstract

The performance of a new dialysis prosthesis designed to self-seal after puncture was tested ex vivo and in vivo. It consists of two coaxial polytetrafluoroethylene tubes (PTFE), the space between them filled with silicone rubber sealant (PTFE-sil). Ex vivo: Three PTFE-sil, three double PTFE (without silicone), and three single PTFE grafts were placed sequentially between scribner shunts in the hind limb of four dogs. Bleeding on puncturing with an 18-gauge needle was measured for 30 seconds. PTFE-sil bled less than the controls (g): PTFE-sil; 16 +/- 18; double PTFE: 32 +/- 10; single PTFE: 52 +/- 19 (p less than 0.001). In vivo: Six PTFE-sil and five single PTFE grafts were interposed between the carotid artery and jugular vein of dogs and were punctured with a 16-gauge needle on days 1, 3, and 7. Bleeding was measured through an incision over the puncture site at 5 minutes. In 11 punctures of PTFE-sil, there was no bleeding; three bled less than 20 g. In 13 control punctures, none bled less than 70 g. Patency: Grafts were studied for patency in arteriovenous (AV) fistulas in 34 dogs. Each dog received a PTFE-sil graft in one groin and a single PTFE control graft in the other. At 4 months, patency rates were: PTFE-sil, 84%; single PTFE, 87% (NS). Four months after implantation, hemostasis after puncture in PTFE-sil grafts required 70 +/- 49 seconds versus 207 +/- 48 seconds for PTFE grafts (p less than 0.005). In conclusion, PTFE-sil grafts are self-sealing, can be used immediately after implantation, and need minimal compression after needle removal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767489      PMCID: PMC1251342          DOI: 10.1097/00000658-198611000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Problems with bovine heterografts for hemodialysis. Recognition, correction, and prevention.

Authors:  J J Rosental; A Spigelman; M R Gaspar; H J Movius
Journal:  Am J Surg       Date:  1975-08       Impact factor: 2.565

2.  Construction of arteriovenous fistulas for hemodialysis.

Authors:  E G Beven; N R Hertzer
Journal:  Surg Clin North Am       Date:  1975-10       Impact factor: 2.741

3.  Cannulation of blood vessels for prolonged hemodialysis.

Authors:  W QUINTON; D DILLARD; B H SCRIBNER
Journal:  Trans Am Soc Artif Intern Organs       Date:  1960 Apr 10-11

4.  A 6 year clinical experience with arteriovenous fistulas and bypass for hemodialysis.

Authors:  V R Zerbino; D A Tice; L A Katz; B D Nidus
Journal:  Surgery       Date:  1974-12       Impact factor: 3.982

5.  Bovine carotid artery shunts in vascular access surgery. Complications in the chronic hemodialysis patient.

Authors:  J H Merickel; R C Anderson; R Knutson; M L Lipschultz; C R Hitchcock
Journal:  Arch Surg       Date:  1974-08

6.  Self-sealing prosthesis for arteriovenous fistula in man.

Authors:  J L Chinitz; T Tokoyama; R Bower; C Swartz
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

7.  Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula.

Authors:  M J Brescia; J E Cimino; K Appel; B J Hurwich
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

8.  Vascular access for dialysis. Technics and results with newer methods.

Authors:  A Morgan; M Lazarus
Journal:  Am J Surg       Date:  1975-04       Impact factor: 2.565

9.  A three year experience using modified bovine arterial heterografts for vascular access in patients requiring hemodialysis.

Authors:  D D Oakes; E K Spees; J A Light; M W Flye
Journal:  Ann Surg       Date:  1978-04       Impact factor: 12.969

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.